176 related articles for article (PubMed ID: 12818683)
21. The 6-phosphogluconate dehydrogenase from Trypanosoma cruzi: the absence of two inter-subunit salt bridges as a reason for enzyme instability.
Esteve MI; Cazzulo JJ
Mol Biochem Parasitol; 2004 Feb; 133(2):197-207. PubMed ID: 14698432
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiprotozoal activity of N-alkoxy analogues of the trypanocidal lead compound 4,4'-bis(imidazolinylamino)diphenylamine with improved human blood-brain barrier permeability.
Nieto L; Mascaraque A; Miller F; Glacial F; Ríos Martínez C; Kaiser M; Brun R; Dardonville C
J Med Chem; 2011 Jan; 54(2):485-94. PubMed ID: 21175162
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
[TBL] [Abstract][Full Text] [Related]
25. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
26. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of azasterols as anti-parasitics.
Gros L; Lorente SO; Jimenez CJ; Yardley V; Rattray L; Wharton H; Little S; Croft SL; Ruiz-Perez LM; Gonzalez-Pacanowska D; Gilbert IH
J Med Chem; 2006 Oct; 49(20):6094-103. PubMed ID: 17004723
[TBL] [Abstract][Full Text] [Related]
29. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
[TBL] [Abstract][Full Text] [Related]
30. Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity.
Eadsforth TC; Pinto A; Luciani R; Tamborini L; Cullia G; De Micheli C; Marinelli L; Cosconati S; Novellino E; Lo Presti L; Cordeiro da Silva A; Conti P; Hunter WN; Costi MP
J Med Chem; 2015 Oct; 58(20):7938-48. PubMed ID: 26322631
[TBL] [Abstract][Full Text] [Related]
31. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
32. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
Bayliss T; Robinson DA; Smith VC; Brand S; McElroy SP; Torrie LS; Mpamhanga C; Norval S; Stojanovski L; Brenk R; Frearson JA; Read KD; Gilbert IH; Wyatt PG
J Med Chem; 2017 Dec; 60(23):9790-9806. PubMed ID: 29125744
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
[TBL] [Abstract][Full Text] [Related]
34. A 2.8 A resolution structure of 6-phosphogluconate dehydrogenase from the protozoan parasite Trypanosoma brucei: comparison with the sheep enzyme accounts for differences in activity with coenzyme and substrate analogues.
Phillips C; Dohnalek J; Gover S; Barrett MP; Adams MJ
J Mol Biol; 1998 Sep; 282(3):667-81. PubMed ID: 9737929
[TBL] [Abstract][Full Text] [Related]
35. Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation.
Woodring JL; Bachovchin KA; Brady KG; Gallerstein MF; Erath J; Tanghe S; Leed SE; Rodriguez A; Mensa-Wilmot K; Sciotti RJ; Pollastri MP
Eur J Med Chem; 2017 Dec; 141():446-459. PubMed ID: 29049963
[TBL] [Abstract][Full Text] [Related]
36. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
[TBL] [Abstract][Full Text] [Related]
37. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds.
Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389
[TBL] [Abstract][Full Text] [Related]
38. QSAR study on the contribution of log P and E(s) to the in vitro antiprotozoal activity of glutathione derivatives.
Daunes S; D'Silva C; Kendrick H; Yardley V; Croft SL
J Med Chem; 2001 Aug; 44(18):2976-83. PubMed ID: 11520206
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, biological evaluation, and molecular modeling of 3,5-substituted-N1-phenyl-N4,N4-di-n-butylsulfanilamides as antikinetoplastid antimicrotubule agents.
George TG; Endeshaw MM; Morgan RE; Mahasenan KV; Delfín DA; Mukherjee MS; Yakovich AJ; Fotie J; Li C; Werbovetz KA
Bioorg Med Chem; 2007 Sep; 15(18):6071-9. PubMed ID: 17618122
[TBL] [Abstract][Full Text] [Related]
40. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis.
Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH
Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
